Efficacy and safety of dupilumab in adult moderate-to-severe atopic dermatitis: An update narrative literature review
Background: Adult atopic dermatitis (AD) is defined as a continuum of childhood AD or the development of the disease in adulthood, accounting for 7.7–59.7% of adult AD cases varying in severity and manifestations. The symptomatology of moderate-to-severe adult AD may significantly impact th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Our Dermatology Online
2022-01-01
|
| Series: | Nasza Dermatologia Online |
| Online Access: | http://www.odermatol.com/issue-in-html/2022-1-2-dupilumab_atopic_derm/ |